{"id":"https://openalex.org/W2230278458","doi":null,"title":"Eficacia y seguridad del bevacizumab en las diferentes patolog\u00edas retinianas","display_name":"Eficacia y seguridad del bevacizumab en las diferentes patolog\u00edas retinianas","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2230278458","mag":"2230278458"},"language":"es","primary_location":{"id":"mag:2230278458","doi":null,"is_oa":false,"landing_page_url":"https://www.medigraphic.com/pdfs/revmexoft/rmo-2006/rmo065i.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2737284857","display_name":"Revista Mexicana de Oftalmolog\u00eda","issn_l":"0187-4519","issn":["0187-4519","2604-1227"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Revista Mexicana de Oftalmolog\u00eda","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071208291","display_name":"Orlando Ustariz-Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. Ustariz\u2013Gonz\u00e1lez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031253479","display_name":"Maximiliano Gordon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Gordon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029654491","display_name":"M M\u00e9ndez Mart\u00ednez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M M\u00e9ndez Mart\u00ednez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5102767636","display_name":"Hugo Quiroz\u2013Mercado","orcid":"https://orcid.org/0000-0001-8482-8777","observed_orcids":["https://orcid.org/0000-0001-8482-8777"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hugo Quiroz\u2013Mercado","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8482-8777","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"80","issue":"5","first_page":"272","last_page":"278"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9950000047683716},{"id":"https://openalex.org/keywords/retinal-disease","display_name":"retinal disease","score":0.7269999980926514},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.8840000033378601},{"id":"https://openalex.org/keywords/age-related-macular-degeneration","display_name":"age-related macular degeneration","score":0.972000002861023},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.9020000100135803},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.8859999775886536},{"id":"https://openalex.org/keywords/retinal-edema","display_name":"retinal edema","score":0.5989999771118164},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/retinal-thickness","display_name":"retinal thickness","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5180000066757202},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9190000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8489367961883545},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.48226314783096313},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.41415148973464966},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.13897967338562012},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.08223378658294678},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2230278458","doi":null,"is_oa":false,"landing_page_url":"https://www.medigraphic.com/pdfs/revmexoft/rmo-2006/rmo065i.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2737284857","display_name":"Revista Mexicana de Oftalmolog\u00eda","issn_l":"0187-4519","issn":["0187-4519","2604-1227"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Revista Mexicana de Oftalmolog\u00eda","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1970142574","https://openalex.org/W2016584341","https://openalex.org/W2042261909","https://openalex.org/W2056392188","https://openalex.org/W2096735172","https://openalex.org/W2233259956","https://openalex.org/W4297917733"],"related_works":["https://openalex.org/W2963915928","https://openalex.org/W4402340804","https://openalex.org/W877666047","https://openalex.org/W7065511513","https://openalex.org/W2210720848","https://openalex.org/W7018718827","https://openalex.org/W4377234222","https://openalex.org/W4391897917","https://openalex.org/W7065212324","https://openalex.org/W2220484321"],"abstract_inverted_index":{"Objetivo:":[0],"Evaluar":[1],"la":[2,13,50,99,106,140,155,177,189,201,211,219],"seguridad":[3,169],"y":[4,20,52,62,76,104,151,170],"eficacia":[5],"del":[6,108,134,149,204],"bevacizumab":[7,27,163,193],"intravitreo":[8],"en":[9,22,35,79,98,105,137,154,173,194],"diferentes":[10,38,174,195],"patologias":[11,39,175,196],"de":[12,53,82,84,91,116,162,168,176,188,192,200,210,218],"retina.":[14,178],"Metodos:":[15],"Estudio":[16],"experimental,":[17],"prospectivo,":[18],"longitudinal":[19],"aleatorizado,":[21],"el":[23,124,180],"cual":[24,141],"se":[25,183,226],"inyecto":[26],"(2.5":[28],"mg":[29],"/0.1":[30],"ml)":[31],"via":[32],"pars":[33],"plana":[34],"pacientes":[36,71,93],"con":[37,49,123,144,147,198],"retinianas":[40],"como":[41],"membranas":[42],"neovasculares":[43],"coroideas":[44],"por":[45,111,206],"degeneracion":[46],"macular":[47,60],"relacionada":[48],"edad":[51,83],"otras":[54],"etiologias,":[55],"retinopatia":[56],"diabetica":[57],"proliferativa,":[58],"edema":[59,207],"diabetico":[61],"oclusiones":[63],"vasculares,":[64],"entre":[65],"otras.":[66],"Resultados:":[67],"De":[68],"los":[69,92],"712":[70],"inyectados,":[72],"48%":[73],"son":[74],"hombres":[75],"52%":[77],"mujeres":[78],"un":[80,166],"rango":[81],"20":[85],"a":[86,113,223],"98":[87],"anos.":[88],"La":[89,159],"mayoria":[90],"presento":[94,184],"mejoria":[95,186,209],"estadisticamente":[96],"significativa":[97],"agudeza":[100,156,212],"visual":[101,213],"mejor":[102,214],"corregida":[103,215],"disminucion":[107],"grosor":[109],"retiniano":[110],"OCT":[112],"3":[114],"meses":[115],"seguimiento.":[117],"No":[118],"hemos":[119,129],"tenido":[120,130],"complicaciones":[121],"relacionadas":[122],"procedimiento":[125],"(inyeccion":[126],"intravitrea).":[127],"Solo":[128],"una":[131,138,185],"inflamacion":[132],"moderada":[133],"segmento":[135],"posterior":[136],"paciente,":[139],"fue":[142,171],"tratada":[143],"antibioticos":[145],"intravitreos,":[146],"resolucion":[148,199],"cuadro":[150],"sin":[152],"afectacion":[153],"visual.":[157],"Conclusiones:":[158],"inyeccion":[160],"intravitrea":[161,191],"demostro":[164],"tener":[165],"perfil":[167],"eficaz":[172],"Durante":[179],"corto":[181],"seguimiento":[182],"despues":[187],"aplicacion":[190],"retinianas,":[197],"permeabilidad":[202],"vascular,":[203],"engrosamiento":[205],"macular,":[208],"e":[216],"inhibicion":[217],"neovascularizacion.":[220],"Los":[221],"efectos":[222],"largo":[224],"plazo":[225],"desconocen.":[227]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}